Noroviruses: State of the Art

被引:91
作者
Atmar, Robert L. [1 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Norovirus; Gastroenteritis; Review; Human; Calicivirus; NORWALK VIRUS-INFECTION; CELLULAR IMMUNE-RESPONSES; BLOOD GROUP ANTIGENS; ACUTE GASTROENTERITIS; SRSV GASTROENTERITIS; UNITED-STATES; SNOW-MOUNTAIN; OUTBREAK; EPIDEMIOLOGY; RESISTANCE;
D O I
10.1007/s12560-010-9038-1
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Noroviruses are a common cause of both endemic and epidemic gastroenteritis. These highly infectious viruses usually cause self-limited disease, but chronic infections occur in highly immunocompromised patients and unusual manifestations are also being described in some populations. Histoblood-group antigen expression is now recognized as an important susceptibility factor for many norovirus strains, but a correlate of acquired immunity to infection or illness has not yet been identified. Currently, treatment and prevention strategies rely on nonspecific measures. However, virus-like particles containing capsid antigens are undergoing evaluation as a vaccine candidate for illness prevention. This article reviews the biologic properties, epidemiology, clinical features, host susceptibility, diagnosis, and treatment and prevention of norovirus infection.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 90 条
  • [1] Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P842
  • [2] [Anonymous], 2002, MMWR-MORBID MORTAL W, V51, P477
  • [3] Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses
    Atmar, RL
    Estes, MK
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (01) : 15 - +
  • [4] Norwalk virus shedding after experimental human infection
    Atmar, Robert L.
    Opekun, Antone R.
    Gilger, Mark A.
    Estes, Mary K.
    Crawford, Sue E.
    Neill, Frederick H.
    Graham, David Y.
    [J]. EMERGING INFECTIOUS DISEASES, 2008, 14 (10) : 1553 - 1557
  • [5] The epidemiologic and clinical impartance of norovirus infection
    Atmar, Robert L.
    Estes, Mary K.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (02) : 275 - +
  • [6] Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study
    Ball, JM
    Graham, DY
    Opekun, AR
    Gilger, MA
    Guerrero, RA
    Estes, MK
    [J]. GASTROENTEROLOGY, 1999, 117 (01) : 40 - 48
  • [7] Norovirus recombination
    Bull, Rowena A.
    Tanaka, Mark M.
    White, Peter A.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 3347 - 3359
  • [8] Cruise Ship Environmental Hygiene and the Risk of Norovirus Infection Outbreaks: An Objective Assessment of 56 Vessels over 3 Years
    Carling, Philip C.
    Bruno-Murtha, Lou Ann
    Griffiths, Jeffrey K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (09) : 1312 - 1317
  • [9] The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection
    Carlsson, Beatrice
    Kindberg, Elin
    Buesa, Javier
    Rydell, Gustaf E.
    Lidon, Marta Fos
    Montava, Rebeca
    Abu Mallouh, Reem
    Grahn, Ammi
    Rodriguez-Diaz, Jesus
    Bellido, Juan
    Arnedo, Alberto
    Larson, Goran
    Svensson, Lennart
    [J]. PLOS ONE, 2009, 4 (05):
  • [10] Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells
    Chang, Kyeong-Ok
    George, David W.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (22) : 12111 - 12118